FDA approves new treatment for Alzheimer’s disease | WNT

June 8, 2021 12:04 am

BioGen’s “Aduhelm” is a monthly injection intended to slow cognitive decline in patients with early stages of the disease. The FDA granted the drug approval as a new clinical trial begins.

WATCH THE FULL EPISODE OF ‘WORLD NEWS TONIGHT’:
https://bit.ly/3x3Vkgr

WATCH OTHER FULL EPISODES OF WORLD NEWS TONIGHT:
http://abc.go.com/shows/world-news-tonight

WATCH WORLD NEWS TONIGHT ON HULU:
https://bit.ly/3iQLwPp

#WorldNewsTonight #Alzheimers #NewTreatment

Category: News
About The Author
-
Previous

What The New Alzheimer’s Disease Drug Means For Patients
Next

Early Signs of Alzheimer’s Disease

Related Videos

NIH-Unraveling-the-Mystery-of-Alzheimers-Disease

NIH: Unraveling the Mystery of Alzheimer’s Disease

Can-What-You-Eat-Help-Prevent-Alzheimers-Disease

Can What You Eat Help Prevent Alzheimer’s Disease?

New-treatment-for-Alzheimers-appears-to-reverse-signs-of-disease-in-brain

New treatment for Alzheimer’s appears to reverse signs of disease in brain

Meet-the-Boston-doctor-behind-breakthrough-nasal-vaccine-for-Alzheimers-disease

Meet the Boston doctor behind breakthrough nasal vaccine for Alzheimer’s disease

Living-with-early-onset-Alzheimers-disease

Living with early onset Alzheimer’s disease

Nasal-vaccine-for-Alzheimers-disease-to-be-tested-at-Boston-hospital

Nasal vaccine for Alzheimer’s disease to be tested at Boston hospital